Tamoxifen and the female genital tract

International Journal of Gynecological Cancer

Volumn 8, Issue 1, 1998, Pages 6-15

  Ugwumadu, A H N ^a,d   Carmichael, P L ^b   Neven, P ^c  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c Saint Jean Clinic of Brussels   (Belgium)

^d George's Hospital Medical School   (United Kingdom)

Author keywords

Progestogens; Surveillance; Tamoxifen; Uterus

Indexed keywords

GESTAGEN; TAMOXIFEN;

ADJUVANT THERAPY; ADULT; ANOVULATION; BREAST CANCER; CONTRACEPTION; DISEASE ASSOCIATION; FEMALE; FEMALE INFERTILITY; HUMAN; PRIORITY JOURNAL; REVIEW; TARGET ORGAN; TREATMENT PLANNING;

EID: 0031912259     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.1998.09726.x     Document Type: Review

References (20)

1. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy. Lancet 1992; 339: 1205.
2. Baum M, Houghton J, Riley D. Results of the Cancer Research Campaign adjuvant trial for perioperative cyclophosphamide and long term tamoxifen in early breast cancer reported at the tenth year of follow-up. Acat Oncol 1992; 31: 251-7.
3. Wright CDP, Mansell RE, Gazet JC, Compston JE. Effect of long term tamoxifen treatment on bone turnover in women with breast cancer. Br Med J 1993; 306: 429-30.
4. McDonald CC, Alexander FE, Whyte BW, Forrest AP, Stewart HJ. Cardiac and vascular morbidity in women receiving adjuvant tamoxifen for breast cancer in a randomised trial. Br Med J 1995; 311: 977-80.
5. Constantino JP, Kuller LH, Ives DC, et al. Coronary heart disease mortality and adjuvant tamoxifen therapy. J Natl Cancer Inst 1997; 89: 776-82.
6. Neven P, De Muylder X, Vanderick G, De Muylder E. Hysteroscopic follow-up during tamoxifen treatment. Eur J Obstet Gynaecol Reprod Biol 1990; 35: 235-8.
7. Fornander T, Cedermark B, Mattson A, et al Adjuvant tamoxifen in early breast cancer: Occurrence of new primary cancers. Lancet 1989; (i): 117-20.
8. Killackey MA, Hakes TB, Pierce VK. Endometrial adenocarcinoma in breast cancer patients receiving anti-oestrogens. Cancer Treat Rep 1985; 69: 237-8.
9. Altaras M, Aviram R, Cohen I, et al. Role of prolonged stimulation of tamoxifen therapy in the etiology of endometrial sarcomas. Gynecol Oncol 1993; 49: 225.
10. Seoud MAF, Johnson J, Weed JC. Gynecologic tumors in tamoxifen-treated women with breast cancer. Obstet Gynecol 1993; 82: 165-9.
11. Rutqvist LE, Johansson H, Signomklao T, el al. Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. J Natl Cancer Inst 1995; 87: 645-51.
12. Daniel Y, Inbar M, Bar-am A, Peyser MR, Lessing JB. The effects of tamoxifen treatment on the endometrium. Fertil Steril 1966; 65: 1083-9.
13. Cuenca RE, Giachino J, Arredondo MA, Hempling R, Edge SB. Endometrial carcinoma associated with breast carcinoma: Low incidence with tamoxifen use. Cancer 1996; 77: 2058-63.
14. Curtis RE, Boice JD Jr, Shriner DA, Hankey BF, Fraumeni JF Jr. Second cancers after adjuvant tamoxifen therapy for breast cancer. J Natl Cancer Inst 1996; 88: 832-4.
15. Wilking N, Isaksson E, von Schoultz E. Tamoxifen and secondary tumours. An update. Drug Safety 1997; 16: 104-17.
16. Rubagotti A, Perrotta A, Casella C, Boccardo F. Risk of new primaries after chemotherapy and/or tamoxifen for early breast cancer. Ann Oncol 1996; 7: 239-44.
17. Cheng WF, Lin HH, Torng PL, Huang SC. Comparison of endometrial changes symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients. Gynecol Oncol 1997; 66: 233-7.
18. Clement PB, Oliva E, Young RH. Mullerian adenosarcoma of the uterine corpus associated with tamoxifen therapy. A report of six cases and a review of tamoxifen-associated endometrial lesions. Int J Gynecol Pathol 1996; 15: 222-9.
19. McCluggage WG, McManus DT, Lioe TF, Hill CM. Uterine carcinosarcoma in association with tamoxifen therapy. Br J Obstet Gynaecol 1997; 104: 748-50.
20. McCluggage WG, Varma M, Weir P, Bharucha H. Uterine leiomyosarcoma in patients receiving tamoxifen therapy. Acta Obstet Gynecol Scand 1996; 75: 593-5.